GPT-Rosalind is designed to support evidence synthesis, hypothesis generation, experimental planning, and multi-step scientific workflows across biochemistry, genomics, and protein engineering.
"This launch, at its core, is about taking our existing agents SDK and making it so it's compatible with all of these sandbox providers," Karan Sharma, who works on OpenAI's product team, told TechCrunch.
Dr. Michael Burry of The Big Short fame doesn't seem to be willing to back down as a bear in the epic tug-of-war with Palantir shareholders and the great CEO Alex Karp. Undoubtedly, Burry seemed to have been getting his way, with shares of Palantir plunging viciously into a bear market amid one of the worst software slumps in recent memory.
OpenAI's GPT-5.2 Pro does better at solving sophisticated math problems than older versions of the company's top large language model, according to a new study by Epoch AI, a non-profit research institute.